Summary by Futu AI
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on June 27, 2024. The transaction was executed at a price of $7.215 per share, resulting in a total market value of $43,290. Following the sale, Marriott's direct holdings in the company amount to 535,457 shares. The sale was conducted on the open market and coincided with the exercise of derivative securities, where Marriott acquired an equivalent number of shares at $1.06 each on the same day.